Since the N terminus of SAA determines its amyloid fibril formation activity [17,18], assessing changes in SAA truncations might provide insight into diseases such as reactive amyloidosis where susceptibility to amyloid formation is dependent on the SAA functionality and clearance. The gene discussed is SAA2; the disease is AA amyloidosis.